Global Neovaginal Surgery Market Size, Trends, and Analysis - Forecast To 2026 By Treatment Type (Vaginal Agenesis Treatment, Vaginal Atresia Treatment [McIndoe Technique, Vecchietti Technique], Sex Reassignment Surgery), By Product (Vaginal Dilators, Vaginal Stents, Laparoscopic Neovaginal Surgeries Kits), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Neovaginal surgeries are largely opted by transgender women and for women suffering from vaginal agenesis. The neovaginal surgery market has been driven by the growing number of gender confirmation surgeries occurring across the world. Insurance coverage of gender confirmation surgeries and the growing availability of insurance schemes especially in developed nations have increased the demand for neovaginal surgeries. The number of women suffering from vaginal agenesis has also been growing in recent years. Vaginal agenesis is a condition that occurs during birth, the baby’s reproductive organs do not complete their development in the mother’s uterus. Vaginal agenesis is estimated to afflict one out of every five thousand to seven thousand female infants. Oftentimes, the defect is identified at birth but in most cases, the defect is not identified until the child reaches puberty. The affliction is identified at puberty as the child will seek medical advice after not starting her period. Neovaginal surgeries can be carried out on women suffering from vaginal agenesis and can greatly improve their quality of life. Transgender women, people who have been assigned as male at birth but identify as women, undertake various medical treatments like feminizing hormone therapy and gender reassignment surgeries for gender confirmation. Neovaginal surgeries occur under gender reassignment surgeries where a neovagina is created through penile inversion, sigmoid colon grafts, scrotal grafts, or through combinations of these surgeries. The growing social acceptance of transgender women has also contributed to the growth of the neovaginal surgery market. Favorable government policies that support transgender individuals who wish to undergo gender reassignment surgeries have also contributed to the growing demand for neovaginal surgeries. In recent years, the technological advancements in neovaginal surgeries have also contributed to the growth of the neovaginal surgery market. Researchers have looked to find various alternatives for the skin grafting surgeries required for neovaginal constructions. The development of new alternatives will result in lower costs and faster treatment than conventional neovaginal surgery. The Federal University of Caera (UFC) in Brazil used the skin of a tilapia fish as an alternative to skin grafting for creating the vaginal canal of a woman suffering from vaginal agenesis. Developing nations like India have also begun providing financial assistance to transgender individuals who wish to undergo such procedures. The COVID-19 pandemic has hampered the number of neovaginal surgeries, the lockdown, and the stress in healthcare facilities have resulted in hospitals rescheduling gender confirmation surgeries. Albeit such issues, the market is expected to bounce back during the forecast period. The American Society of Plastic Surgeons estimates shows that gender affirmation surgeries increased by almost 15% between 2018 and 2019 in the United States alone.
Based on the various treatments offered, the neovaginal surgery market can be segmented into vaginal agenesis treatment, vaginal atresia treatment, and sex reassignment surgery segments. The vaginal atresia treatment segment includes techniques like Mcindoe andVecchietti. The sex reassignment surgery segment held the lion’s share of the market during the forecast period. This segment held the dominant share due to the large demand for gender affirmation surgeries especially from male to female surgeries. Healthcare insurance coverage for such surgeries and the growing acceptance of such surgeries have been the major drivers of the market.
Based on product, the neovaginal surgery market can be segmented into vaginal dilators, vaginal stents, and laparoscopic neovaginal surgery kits. The laparoscopic neovaginal surgeries segment is expected to hold the dominant share of the market and register the fastest growth rate during the forecast period. The dominance of laparoscopic procedures has been due to the rising demand for this surgery to treat vaginal agenesis. Laparoscopic procedures are minimally invasive and the growing demand for minimally invasive procedures to treat vaginal agenesis is expected to increase the demand for laparoscopic neovaginal surgery kits during the forecast period. Laparoscopic surgery reduces the risk of adenocarcinoma, colitis, scarring of the neovagina, prolapse, and intestinal obstruction, among other advantages.
The European region is expected to hold the dominant share of the market during the forecast period. The growing demand for vaginoplasty procedures in the region is one of the major drivers of the market in this region. The region has been conducting extensive research on developing new treatment techniques which have contributed to the increasing demand for neovaginal surgeries. Favorable policies and regulations that ensure a high degree of safety have also contributed to the large demand in the region. The growing social acceptance of such procedures is also expected to increase the demand for products like laparoscopic neovaginal surgery kits, vaginal stents, and dilators that are used in neovaginal surgeries. The APAC region is expected to register the fastest growth rate during the forecast period. The increasing number of gender change surgeries by insurance providers, growing medical tourism, a growing number of skilled labor force, and the growing number of facilities that provide neovaginal surgeries are expected to increase the demand in this region during the forecast period.
González-Fontana, Owen Mumford Ltd., Icahn School of Medicine at Mount Sinai, Phuket Plastic Surgery Institute (PPSI), Chettawut Plastic Surgery Center, KESSEL medintim GmbH, Vuvatech, among others, are the major vendors competing in the neovaginal surgery market.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Neovaginal Surgery Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Neovaginal Surgery Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?